Nouri-Mahdavi Kouros, Caprioli Joseph
The Jules Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Br J Ophthalmol. 2015 Jul;99(7):893-8. doi: 10.1136/bjophthalmol-2014-305210. Epub 2014 Oct 6.
Glaucoma is a progressive optic neuropathy. Hence, most glaucomatous eyes demonstrate signs of deterioration over time despite what may appear to be adequate treatment. The main goal of glaucoma treatment is to slow the rate of disease so that patients can prolong their functional vision. Therefore, it is important for clinicians caring for patients with glaucoma to be able to estimate rates of change with structural and functional outcomes in their patients. Various trend analysis models have been previously used to estimate rates of decay in glaucoma. The authors discuss the relevant issues and the inherent caveats related to estimating structural and functional rates of change in glaucoma. Patterns of deterioration, testing frequency, and combing structural and functional rates of change are also addressed.
青光眼是一种进行性视神经病变。因此,大多数青光眼患者的眼睛尽管接受了看似充分的治疗,但随着时间的推移仍会出现病情恶化的迹象。青光眼治疗的主要目标是减缓疾病进展速度,以便患者能够延长其功能性视力。因此,对于照顾青光眼患者的临床医生来说,能够评估患者结构和功能预后的变化率非常重要。此前已经使用了各种趋势分析模型来估计青光眼的病情衰退率。作者讨论了与估计青光眼结构和功能变化率相关的问题及内在的注意事项。还探讨了病情恶化模式、检测频率以及结构和功能变化率的综合问题。